Chronic obstructive pulmonary disease in the adult population within the Middle East and North Africa region: rationale and design of the BREATHE study

被引:30
|
作者
El Hasnaoui, Abdelkader [1 ]
Rashid, Nauman [1 ]
Lahlou, Aicha [2 ]
Salhi, Hocine [3 ]
Doble, Adam [3 ]
Nejjari, Chakib [4 ]
机构
[1] GlaxoSmithKline, Dubai, U Arab Emirates
[2] MS Hlth, Rabat, Morocco
[3] Foxymed, Paris, France
[4] Univ Fez, Dept Epidemiol, Fes, Morocco
关键词
COPD; Middle East; North Africa; BREATHE study; Epidemiology; Prevalence; Smoking; COPD ASSESSMENT TEST; BURDEN; PREVALENCE; HEALTH; EPIDEMIOLOGY; PREVENTION; MANAGEMENT; SMOKING;
D O I
10.1016/S0954-6111(12)70010-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The objective of the BREATHE study was to estimate the regional prevalence of chronic obstructive pulmonary disease (COPD) symptoms within the general population in the Middle East/North Africa (MENA) region and to document risk factors, disease characteristics and management using a standardised methodology. This was an observational population-based survey performed in ten countries in the Middle East and North Africa (Algeria, Egypt, Jordan, Lebanon, Morocco, Saudi Arabia, Syria, Tunisia, Turkey and United Arab Emirates), together with Pakistan. A general population sample of 10,000 subjects >= 40 years of age in each country or zone was generated from random telephone numbers. Structured interviews were proposed by telephone. A screening questionnaire was administered to each subject collecting information on respiratory symptoms and smoking habits. Subjects with chronic bronchitis or breathlessness and smoking >= 10 pack years fulfilled the epidemiological definition of COPD ("COPD" population). This population then completed a full disease questionnaire, the COPD Assessment Test (CAT) and a cost-of-disease questionnaire. A randomly selected sample was also assessed by spirometry. In all, 457,258 telephone numbers were generated and contact was established with 210,121 subjects, of whom 65,154 were eligible and 62,086 accepted to participate. The overall response rate was 74.2%. 2,187 (3.5%) subjects fulfilled the criteria for the "COPD" population. Evaluable spirometry data were obtained from 1,847 (14.2%) subjects to whom it was proposed.
引用
收藏
页码:S3 / S15
页数:13
相关论文
共 50 条
  • [41] Systemic corticosteroids in chronic obstructive pulmonary disease exacerbations (SCCOPE): Rationale and design of an equivalence trial
    Erbland, ML
    Deupree, RH
    Niewoehner, DE
    CONTROLLED CLINICAL TRIALS, 1998, 19 (04): : 404 - 417
  • [42] The burden of rheumatic heart disease in the Middle East and North Africa region, 1990-2019
    Safiri, Saeid
    Mousavi, Seyed Ehsan
    Noori, Maryam
    Nejadghaderi, Seyed Aria
    Sullman, Mark J. M.
    Singh, Kuljit
    Kolahi, Ali-Asghar
    ARCHIVES OF CARDIOVASCULAR DISEASES, 2023, 116 (12) : 542 - 554
  • [43] Serum Procalcitonin Levels in Chronic Obstructive Pulmonary Disease Patients in North Indian Population
    Pandey, Sarika
    Garg, Rajiv
    Kant, Surya
    Verma, Ajay
    Gaur, Priyanka
    ANNALS OF AFRICAN MEDICINE, 2019, 18 (02) : 103 - 107
  • [44] The Burden of Ischemic Heart Disease in North Africa and Middle East Region From 19902019: Results From the GBD Study
    Aminorroaya, Arya
    Moghaddam, Sahar Saeedi
    Tavolinejad, Hamed
    Aryan, Zahra
    Heidari, Behnam
    Ebrahimi, Hedyeh
    Naderian, Mohammadreza
    Shobeiri, Parnian
    Ghanbari, Ali
    Rezaei, Nazila
    CIRCULATION, 2023, 148
  • [45] Screening and early diagnosis of chronic obstructive pulmonary disease: a population study
    Wenhui Tang
    Yan Rong
    Hongmei Zhang
    Wenji Lin
    Wenmei Zeng
    Wenhong Wu
    BMC Pulmonary Medicine, 23
  • [46] Screening and early diagnosis of chronic obstructive pulmonary disease: a population study
    Tang, Wenhui
    Rong, Yan
    Zhang, Hongmei
    Lin, Wenji
    Zeng, Wenmei
    Wu, Wenhong
    BMC PULMONARY MEDICINE, 2023, 23 (01)
  • [47] Prevalence and predictors of undiagnosed chronic obstructive pulmonary disease in a Norwegian adult general population
    Hvidsten, Sophie Charlotte
    Storesund, Lene
    Wentzel-Larsen, Tore
    Gulsvik, Amund
    Lehmann, Sverre
    CLINICAL RESPIRATORY JOURNAL, 2010, 4 (01): : 13 - 21
  • [48] Population pharmacokinetics of theophylline in adult Chinese patients with asthma and chronic obstructive pulmonary disease
    Yanjiao Ma
    Ling Xue
    Xin Chen
    Yingbo Kang
    Yong Wang
    Liqing Wang
    International Journal of Clinical Pharmacy, 2018, 40 : 1010 - 1018
  • [49] Population pharmacokinetics of theophylline in adult Chinese patients with asthma and chronic obstructive pulmonary disease
    Ma, Yanjiao
    Xue, Ling
    Chen, Xin
    Kang, Yingbo
    Wang, Yong
    Wang, Liqing
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2018, 40 (05) : 1010 - 1018
  • [50] Incidence of GOLD-defined chronic obstructive pulmonary disease in a general adult population
    Johannessen, A
    Omenaas, E
    Bakke, P
    Gulsvik, A
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2005, 9 (08) : 926 - 932